Magnify Ventures Fund II has closed at $46.6 million, with Melinda French Gates’ Pivotal Ventures returning as a key limited partner after anchoring the firm’s debut vehicle three years ago.
The San Francisco-based early-stage firm, founded in 2021 by Joanna Drake and Julie Wroblewski, invests in what its founders call the care economy: technology built around the rhythms of household life, family finance, health at home, and the needs of an ageing population. Fund II will direct capital into AI tools for households, health and home systems, and fintech infrastructure for families.
Inside the Magnify Ventures Fund II Thesis
The new fund is smaller than its predecessor. Magnify’s Fund I raised $52 million in 2022, spanning parenting and family life, the future of work, household optimisation, and ageing and longevity. Fund II sharpens that scope around artificial intelligence and infrastructure, reflecting where the founders see the sector heading.
Wroblewski told Forbes that she views care economy and family technology as ‘a very compelling and growing category for investment in venture.’ Drake was initially more cautious, describing the space as ‘slightly niche and more of a lived experience than a category.’ Between them, the two perspectives shaped a thesis that tries to be rigorous rather than sentimental about where care economy technology actually generates returns.
The scale of the underlying market gives that thesis room to breathe. Economist Nancy Folbre, whose work focuses on the care economy’s relationship to gender, has argued that it ‘is way more than half of GDP that is currently measured’, a figure that pushes back hard on the assumption that the category is a niche adjacent to healthcare. For Magnify, the bet is that infrastructure has lagged the human reality of how people organise their domestic lives.
A Narrower Care Economy, A Smaller Fund
The portfolio from Fund I shows the breadth of that original mandate. Magnify’s current holdings include childcare startup Kinside and children’s expense management startup Till Financial. The firm also backed Papa, a caregiving platform in which Pivotal Ventures was a co-investor, alongside companies including Alix, MiSalud Health, Nolia Health, and Savi Security.
Pivotal Ventures occupies an unusual position in this ecosystem. It operates as both a general partner and a limited partner, backing companies across the care economy directly while also anchoring funds like Magnify’s. Its investments in Papa and Seen Health sit alongside its LP commitment to Magnify, creating overlapping exposures that the two firms appear content to share rather than avoid.
In 2024, Magnify launched what it described as a first-of-its-kind Care Summit, a gathering designed to spotlight companies in the sector, surface investment trends, and build partnerships across the ecosystem. The event reflected the firm’s positioning as something beyond a capital allocator in the space.
The Fund II close lands as AI has become the organising principle of nearly every early-stage investment thesis. For Magnify, the question is whether focusing AI’s application on the household rather than the enterprise gives the firm a durable angle, or simply reframes a broad technology bet in more sympathetic language. The portfolio companies it backs over the next two to three years will supply the answer.
